Shaban Athuman
/
VPM News
Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
RVA's Got Issues
VPM 60th Anniversary
Virginia News
NPR News
Virginia News
-
The funding is still contingent on General Assembly approval. -
The phrase, reportedly coined in Richmond to persuade Virginia colonists to prepare for war, has been used by protesters across the world.
-
The $11.4B federal ‘claw back’ has led to layoffs and public health cuts nationwide.
-
The spending plan includes a $426M water treatment plant that could be online by 2033.
-
The governor removed a barrier to local betting parlors despite bipartisan support.
-
The governor axed another Democrat-led effort to create a legal retail market.
NPR News
-
McBride, a Georgia native, has seen how Hollywood traffics in stereotypes about the American South. His HBO show satirizes televangelists without making religious people the butt of the joke.
-
Kosmos 482 rocketed into space in 1972 on a quest to reach Venus, but its journey was scuttled by an apparent engine malfunction.
-
More than 30,000 people have already voted in the election for the president of the D.C. Bar Association, more than triple the previous record set in 1990.
-
Stocks rallied after the U.S. and China said they would slash tariffs on each other's imports for 90 days.
-
Pope Leo XIV once attended Villanova University. Catholics packed the St. Thomas of Villanova church to celebrate Sunday Mass and the new pope.
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal